Tag Archives | Henry J. Fuchs

Genomic Health: Proxy Score 60

Genomic Health, Inc. (NASD:GHDX), one of the stocks in my portfolio, is a molecular diagnostics company focused on the global development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. Their annual meeting is coming up on 6/11/2015. ProxyDemocracy.org had the vote of one […]

Continue Reading ·

Powered by WordPress. Designed by WooThemes